Palisade Bio (PALI) Net Margin Growth (1y) (2012 - 2020)

Palisade Bio (PALI) Net Margin Growth (1y) (2012 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Palisade Bio 985.76 -132.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -4.52 Mn
Sep 30, 2020 1.28 Mn
Jun 30, 2020 -5.15 Mn
Mar 31, 2020 5.90 Mn
Dec 31, 2019 -1.36 Mn
Sep 30, 2019 -408,484.00
Jun 30, 2019 -2.36 Mn
Mar 31, 2019 -207,676.00
Dec 31, 2018 -7.05 Mn
Sep 30, 2018 2.02 Mn
Jun 30, 2018 17.89 Mn
Mar 31, 2018 7.95 Mn
Dec 31, 2017 6.40 Mn
Sep 30, 2017 10.28 Mn
Jun 30, 2017 -1.39 Mn
Mar 31, 2017 8.78 Mn
Dec 31, 2016 12.57 Mn
Sep 30, 2016 2.00 Mn
Jun 30, 2016 5.22 Mn
Mar 31, 2016 -9.11 Mn